ArticleTheranostics2018
PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
Jin Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this papercites it
ArticleTheranostics2018
Jin Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.